Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory factor X associated protein (RFXAP) is a transcription factor and coactivator within the RFX complex that binds to the X-box motif in the promoters of MHC class II genes and is required for their transcriptional activation[1][2][3][4]. The RFX complex, which includes RFXAP, RFXANK, and RFX5, enables the expression of MHC class II molecules, which are critical for antigen presentation and activation of the adaptive immune response via T cells[1][2][4]. Mutations in the RFXAP gene can cause bare lymphocyte syndrome type II, a rare but severe immunodeficiency disease[1][3][4]. While RFXAP itself is not a direct drug target, its role in immune modulation makes its pathway of interest for therapeutics aimed at altering MHC class II expression[4].
Not directly targeted; biological mechanisms involve transcriptional activation of MHC class II genes via the RFX complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory factor X associated protein (RFXAP).